Fachliteratur Gastroenterologie: Neoplasien der Leber

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Leber » Neoplasie

26. April 2024

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3443


	Artikel 1 - 20 / 68844

	Local Tumor Progression Predictive Model Based on MRI for Colorectal Cancer Liver Metastases after Radiofrequency Ablation. Discov Med Zhang G, Liu P, Wang G, He X, Xu L, Wang Y, Li W, Peng W. PMID: 38665025 [PubMed - indexed for MEDLINE]
	Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-ÎºB/MMP9 Axis. Discov Med Li J, Cai Q, Wang Z, Wang L, Yang G, Zhang Z, Ge N, Hu S, Bai T. PMID: 38665016 [PubMed - indexed for MEDLINE]
	Retrospective Dosimetry for Yttrium-90 Radioembolization with Resin Microspheres. J Vasc Interv Radiol Kappadath SC. PMID: 38663954 [PubMed - indexed for MEDLINE]
	Kommentar zu â€žINTERVENTION â€“ Mit dem SMARS-Score proliferative Leberkarzinome identifizierenâ€œ. Rofo Geith T, Paprottka PM. PMID: 38663379 [PubMed - indexed for MEDLINE]
	Predicting the immunity landscape and prognosis with an NCLs signature in liver hepatocellular carcinoma. PLoS One Ji Z, Zhang C, Yuan J, He Q, Zhang X, Yang D, Xu N, Chu J. PMID: 38662757 [PubMed - indexed for MEDLINE]
	Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohort. Br J Surg Korenblik R, Heil J, Smits J, James S, Olij B, Bechstein WO, Bemelmans MHA, Binkert CA, Breitenstein S, Williams M, Detry O, Dewulf MJL, Dili A, Grochola LF, Grote J, Heise D, Kalil JA, Metrakos P, Neumann UP, Pappas SG, Pennetta F, Schnitzbauer AA, Tasse JC, Winkens B, Olde Damink SWM, van der Leij C, Schadde E, van Dam RM, DRAGON trials collaborative. PMID: 38662462 [PubMed - indexed for MEDLINE]
	Feasibility Study of Computed Tomographic Radiomics Model for the Prediction of Early and Intermediate Stage Hepatocellular Carcinoma Using BCLC Staging. Technol Cancer Res Treat Dong H, Yang L, Shaofeng D, Lili G. PMID: 38660703 [PubMed - indexed for MEDLINE]
	A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy. Front Immunol Li M, Liao J, Wang L, Lv T, Sun Q, Xu Y, Guo Z, Quan M, Qin H, Yu H, Zhang K, Xing W, Yu H. PMID: 38660298 [PubMed - indexed for MEDLINE]
	Hepatic perivascular epithelioid cell tumors: The importance of preoperative diagnosis. World J Gastroenterol Yan S, Lu JJ, Chen L, Cai WH, Wu JZ. PMID: 38659487 [PubMed - indexed for MEDLINE]
	Incidentally found parotid gland lesion in (18)F-FDG PET/CT for staging evaluation of patients with hepatocellular carcinoma: remote possibility of metastatic tumor or second primary salivary gland malignancy. BMC Surg Jung JH, Lee YS, Jung YH, Choi SH, Nam SY, Cho HJ, Kwon M. PMID: 38658868 [PubMed - indexed for MEDLINE]
	Identification of drug responsible glycogene signature in liver carcinoma from meta-analysis using RNA-seq data. Glycoconj J Koreeda T, Honda H. PMID: 38656600 [PubMed - as supplied by publisher]
	Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs. BMC Gastroenterol Wei M, Lu L, Luo Z, Ma J, Wang J. PMID: 38654165 [PubMed - indexed for MEDLINE]
	Prognostic analysis of radiation-induced liver damage following carbon-ion radiotherapy for hepatocellular carcinoma. Radiat Oncol Hayashi K, Suzuki O, Wakisaka Y, Ichise K, Uchida H, Anzai M, Hasegawa A, Seo Y, Shimizu S, Ishii T, Teshima T, Fujimoto J, Ogawa K. PMID: 38649902 [PubMed - indexed for MEDLINE]
	Case report: A rare immune-related adverse effect: hepatic cavernous hemangioma induced by camrelizumab. Front Immunol Zhang C, Wang G, Liu N, Li T, Zhu J, Hou H. PMID: 38646529 [PubMed - indexed for MEDLINE]
	Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs. Sci Rep Wei Q, Luo S, He G. PMID: 38644382 [PubMed - indexed for MEDLINE]
	Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years. Sci Rep Chen TC, Hsiao SW, Chen YY, Yen HH, Su WW, Hsu YC, Huang SP, Su PY. PMID: 38643245 [PubMed - indexed for MEDLINE]
	'Burn and Push' technique: A novel robotic liver parenchymal transection technique. Int J Med Robot Sambommatsu Y, Lee SD, Imai D, Savsani K, Khan AA, Sharma A, Saeed M, Cotterell AH, Kumaran V, Levy MF, Bruno DA. PMID: 38642395 [PubMed - indexed for MEDLINE]
	Factor modification in the association between high-density lipoprotein cholesterol and liver cancer risk in a nationwide cohort. Int J Epidemiol Nam SY, Jo J, Lee WK, Cho CM. PMID: 38641427 [PubMed - indexed for MEDLINE]
	Prognostic impact of CD68+ tumor-associated macrophages in hepatocellular carcinoma: A meta-analysis. Medicine (Baltimore) Jin D, Qian L, Chen J, Yu Z, Dong J. PMID: 38640338 [PubMed - indexed for MEDLINE]
	ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis Resection. JAMA Netw Open Achterberg FB, Bijlstra OD, Slooter MD, Sibinga Mulder BG, Boonstra MC, Bouwense SA, Bosscha K, Coolsen MME, Derksen WJM, Gerhards MF, Gobardhan PD, Hagendoorn J, Lips D, Marsman HA, Zonderhuis BM, Wullaert L, Putter H, Burggraaf J, Mieog JSD, Vahrmeijer AL, Swijnenburg RJ, Dutch Liver Surgery Group. PMID: 38639939 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 68844

Seite 1 von 3443



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung